Steris | STE - Assets


Steris reported $10.74B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
3M USD 34.92B 512M Jun/2026
Accuray USD 448.01M 8.81M Dec/2025
Baxter International USD 19.79B 55M Jun/2026
Becton, Dickinson and Co. USD 50.83B 4.01B Mar/2026
Boston Scientific USD 45.22B 865M Jun/2026
CONMED USD 2.3B 14.64M Jun/2026
Cooper Companies USD 12.48B 58.1M Mar/2026
Dexcom USD 6.46B 178M Jun/2026
Ecolab USD 29.93B 4.89B Jun/2026
Edwards Lifesciences USD 13.87B 545.9M Jun/2026
Fortive USD 11.62B 30.9M Jun/2026
Getinge SEK 57.37B 6.55B Jun/2026
Globus Medical USD 5.44B 136.79M Mar/2026
Haemonetics USD 2.4B 94.96M Mar/2026
Idexx Laboratories USD 3.44B 56.84M Jun/2026
Inogen USD 307.01M 5.03M Sep/2025
Insulet USD 3.17B 177.9M Jun/2026
Integra LifeSciences USD 3.56B 14.24M Jun/2026
Intuitive Surgical USD 20.88B 765.6M Jun/2026
J&J USD 201.06B 167M Jun/2026
Olympus JPY 1.54T 79.24B Mar/2026
Orthofix International USD 873.02M 13.58M Jun/2026
Owens Minor USD 2.42B 35.78M Mar/2026
ResMed USD 8.78B 280.91M Mar/2026
Steris USD 10.74B 145.8M Mar/2026
Stryker USD 47.93B 1.64B Jun/2026
Tandem Diabetes Care USD 1.15B 272.28M Mar/2026
Teleflex USD 6.78B 164.24M Mar/2026
Thermo Fisher Scientific USD 113.17B 107M Jun/2026
Zimmer Biomet Holdings USD 22.8B 76.2M Jun/2026